抗药性感染的疗法:科学证据,临床接受和实践之间的脱节
Joseph Coombes1, John Gammon1, Yamni Nigam1
1School of Health and Social Care, Faculty of Medicine, Health and Life Sciences, Swansea University, Wales.
Journal of wound care
|July 5, 2024
概括
疗法 (MT) 是一种未被充分利用的,负担得起的伤口护理疗法,有效应对抗菌素耐药性 (AMR). 需要增加研究和公众参与,以克服误解,并扩大其在AMR感染管理中的使用.
科学领域:
- 伤口护理和再生医学
- 传染病和微生物学 传染病和微生物学
- 生物医学工程 生物医学工程
背景情况:
- 抗菌素耐药性 (AMR) 需要探索替代性和补充性治疗策略.
- 疗法 (MT) 是一种未被充分利用的,具有成本效益的伤口护理方式,具有经过验证的除菌和消毒能力.
- 目前在英国的MT使用占伤口护理开支的最小部分,这表明增加采用有很大的潜力.
研究的目的:
- 调查在临床实践中使用治疗 (MT) 的原因.
- 评估MT在管理感染方面的有效性,特别是那些涉及抗菌素耐药性 (AMR) 的感染.
- 确定增强未来MT应用的策略,以改善患者的治疗结果和打击AMR.
主要方法:
- 系统审查遵循系统审查和元分析 (PRISMA) 准则的首选报告项目.
- 对涉及AMR感染的MT的案例研究进行定性分析.
- 随机对照试验 (RCT) 的定量分析,评估MT疗效.
主要成果:
- 在各种感染和伤口类型中,MT表现出高效率,与传统治疗相美.
- 对于MT的采用障碍包括"的因素",以及关于成本,有效性和可访问性的误解.
- 需要进一步的RCT来确定MT在各种临床表现中的活性和疗效范围.
结论:
- 疗法 (MT) 是一种未被充分利用但有价值的治疗选择,特别是在AMR感染中.
- 扩大MT的使用可以帮助保持现有的抗微生物药物的有效性,并支持抗微生物药物管理计划.
- 专业和公众参与活动,以及进一步的研究,对于增加MT的临床整合至关重要.
关键词:
抗微生物耐药性 抗微生物耐药性临床验收 临床验收拆分 拆分 拆分 拆分 拆分药物耐药性 耐药性 药物耐药性幼虫疗法 幼虫疗法疗法是一种疗法.这是微生物的微生物.伤口的伤口是伤口.伤口护理 伤口护理伤口上使用了伤口带.伤口愈合 伤口愈合更多相关视频
相关概念视频
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
2.5K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
2.5K
Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Microbial Interactions: Parasitism
108
Parasitism is a form of microbial interaction in which parasitic microbes exploit a host organism for nutrients and shelter, often at the host's expense. Unlike mutualistic relationships, where both organisms benefit, parasitism benefits only the parasite and harms the host.Classification of ParasitesMicrobial parasites are broadly classified based on their location relative to the host.Ectoparasites remain on the host’s surface, such as the skin or outer tissues, drawing nutrients...
108
Mechanism of Antibiotic Resistance in MRSA
219
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
219
Anthelminthic Agents
103
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
103
Clinical Significance of Antibiotic Resistance
90
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90


